Medications

Study: Anti-obesity medications could be sold for lower prices

New research shows that several anti-obesity medications could be manufactured and profitability sold worldwide at far lower estimated lower prices compared to their high costs, according to a new study in Obesity, The Obesity ...

Neuroscience

A new peptide may hold potential as an Alzheimer's treatment

MIT neuroscientists have found a way to reverse neurodegeneration and other symptoms of Alzheimer's disease by interfering with an enzyme that is typically overactive in the brains of Alzheimer's patients.

Vaccination

Report: Florida officials cut key data from vaccine study

An analysis that was the basis of a highly criticized recommendation from Florida's surgeon general cautioning young men against getting the COVID-19 vaccine omitted information that showed catching the virus could increase ...

Medications

AAD: Long-term improvement seen with ruxolitinib in vitiligo

For patients with nonsegmental vitiligo, continued improvement in seen during a long-term extension of ruxolitinib treatment, according to study presented at the annual meeting of the American Academy of Dermatology, held ...

Medications

Not enough new antibiotics in the pipeline, WHO review concludes

A review from WHO on the number of new antibiotics currently in the pipeline shows that just 12 new antibiotics have entered the market in the five years from 2017-21. And there are far too few (just 27) under development ...

page 10 from 40